Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

The US has pioneered advanced technologies in almost all economic sectors only to watch the subsequent commercialization, ...

Former congressman Michael Burgess opposes a White House executive order that ties U.S. drug prices to the artificially low, ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

It is predicted that the first new drug developed by artificial intelligence (AI) may be commercialized in 2030. Alex ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

According to brokerage Jefferies, the average drug development cycle spans 8 to 10 years, with success rates below 10% and ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, has ...

Keros Therapeutics Inc (NASDAQ:KROS) released topline data from the TROPOS Phase 2 trial of cibotercept (KER-012) in ...